Yiwei Shi (易维适)易维适

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

药物知识说明

乙酰半胱氨酸是一种在国家药监局注册认定的药品。标注生产企业为广东人人康药业有限公司。

该药品暂无关联的活性成分信息。

该药品标注的生产企业为:广东人人康药业有限公司Chinese legal name: 广东人人康药业有限公司、广东人人康药业有限公司Chinese legal name: 广东人人康药业有限公司、广东人人康药业有限公司Chinese legal name: 广东人人康药业有限公司。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 易维适) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 广东人人康药业有限公司.

No active ingredient relationships are currently recorded for this product in MedicineGraph.

Manufacturers recorded for this product: 广东人人康药业有限公司Chinese legal name: 广东人人康药业有限公司, 广东人人康药业有限公司Chinese legal name: 广东人人康药业有限公司, 广东人人康药业有限公司Chinese legal name: 广东人人康药业有限公司.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 易维适Recorded Chinese name: 易维适
  • 剂型Dosage form: 胶囊剂Capsules
  • 规格Specification: 0.2g*12粒0.2 g × 12 capsules

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 广东人人康药业有限公司Chinese legal name: 广东人人康药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20000519

关联实体Relationships

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20000519

Manufacturer

Chinese legal name: 广东人人康药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

0.2 g × 12 capsules

中文说明书原文Original Chinese source label

批准文号

国药准字H20000519

生产企业

广东人人康药业有限公司(国产)

适应症

本品用于浓稠痰粘液过多的呼吸系统疾病:急性支气管炎、慢性支气管炎急性发作、支气管扩张症。

用法用量

口服。成人,每次0.2g,每日2~3次。

不良反应

偶尔发生恶心和呕吐,极少出现皮疹和支气管痉挛等过敏反应。

禁忌

1.对本品过敏者禁用。
2.支气管哮喘患者慎用或禁用。

注意事项

支气管哮喘患者在用本品期间应严密监控,如发生支气管痉挛须立即停药。

贮藏

密封,在阴凉干燥处保存。

规格

0.2g*12粒

证据Evidence

  • 批准文号: 国药准字H20000519
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.